CLINICAL_TRIALS
trial_result
· 2021-01-11
Clinical Trial Update: Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS) [Phase 3]
Summary
Phase 3 trial update on tofacitinib for active ankylosing spondylitis with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Ankylosing Spondylitis | Phase 3 | Status: COMPLETED | Results posted: 2021-01-11